Operating Profit Cambiamento Data
AbbVie USD 3.2B 914M 2023-12
Abbott USD 1.79B 119M 2023-12
Amgen USD 1.27B 819M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Avrobio USD -22933000 90.94M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
J&J USD 4.83B 391M 2023-12
Merck USD -1933000000 7.68B 2023-12
Nektar Therapeutics USD -44864000 5.74M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Takeda JPY -49342000000 217.91B 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Xencor USD -35009000 16.74M 2023-12



Karyopharm Therapeutics L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.